July - August,2021
Tomorrow’s vaccine and drug discovery
A total of some 30,000 people in the U.S. and Mexico, 44 per cent non-white, participated in the trial. The vaccine was 90.4 per cent effective in those with symptoms of COVID-19 and 100 per cent successful in moderate and severe cases.
